Shocking is coming! Recently, the traditional Chinese medicine industry has set off a strong momentum, attracting the attention of many investors. Industry insiders can't help but sigh: another big demon who is about to rise has appeared! This year, the traditional Chinese medicine industry is not only driven by policies, but also benefits from the blessing of the moat of traditional Chinese medicine brands. At the same time, the performance of the fundamentals has also maintained stable growth, especially in the first quarter, which exceeded expectations. As a result, many ** have frequently hit new highs recently, including Tong Ren Tang and China Resources.
Three. 9. Kangyuan Pharmaceutical, etc. 
However, in the short term, the valuations of these ** have been elevated, and the upside is far less than the downside. At present, funds are mainly rapidly rotated between various fields, and artificial intelligence and special valuation are the main lines that are relatively certain, while the field of traditional Chinese medicine is temporary"Sit on a cold bench"。However, when the emotional fermentation and hype in artificial intelligence and other fields are completed, the overflow of funds will look for industries with low valuations and high certainty, and the large industry of traditional Chinese medicine will become a good reservoir of funds. After nearly half a year of continuous observation and analysis day and night, I recently discovered a dark horse Chinese medicine demon. It's currently about 733 yuan, net assets as high as 2957, and the market circulation value is only 430.7 billion. Surprisingly, the stock turned over a whopping 3028%, showing a lot of trading activity. Quarterly results increased by 98% year-over-year65, the annual report is expected to grow by 568%. The Chinese medicine sector continues to be positively promoted, and the quality of the company is very good, and the annual report is expected to grow by 16 times, which is expected to continue to benefit from the high growth of the industry. The prototype of this dark horse Chinese medicine demon has appeared, and all parties have been continuously blessed. If you didn't make a good profit in the first quarter, then take a good look at this **! This could be a great investment opportunity! 
As an important part of China's traditional medicine culture, the traditional Chinese medicine industry has always attracted much attention from the market. In recent years, with the enhancement of people's health awareness and the importance of traditional culture, the traditional Chinese medicine market has shown a vigorous development trend. The support of policies and the moat of traditional Chinese medicine brands provide a strong guarantee for the traditional Chinese medicine industry. At the same time, the fundamentals of the Chinese medicine industry have also shown a steady growth trend. It is understood that the performance in the first quarter of this year exceeded market expectations and showed a strong growth momentum. In the current capital market environment, the level of valuation directly affects the judgment of investors. Although Tongrentang and China Resources.
Three. 9. Kangyuan Pharmaceutical and other traditional Chinese medicines** have performed strongly, but their valuations have been relatively high, and the upward space is limited. However, let's be clear, short-term ups and downs do not completely determine the value of a **. In the medium to long term, the Chinese medicine industry still has good investment potential.